GT3Cer (d20:1/16:0) is a glycosphingolipid containing three sialic acids, which can be used as an effective standard in the research of immunotherapy methods.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.